Fovus Revolutionizes HPC for Drug Discovery
Fovus uses AI to simplify HPC, cutting costs and boosting speed for drug discovery in pharma and biotech sectors.
- Latest
- Trending
Fovus uses AI to simplify HPC, cutting costs and boosting speed for drug discovery in pharma and biotech sectors.
AI in drug discovery market to skyrocket, reaching USD 11,874.24 million by 2032, with a CAGR of 37.5%.
Tecan reports lower H1 2024 sales, revises full-year outlook due to biopharma sector weakness and market challenges in China.
23andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
Bio-Techne shows resilience with strategic growth in diagnostics despite fiscal year challenges and market declines.
Veracyte's Q2 revenue surged 27% to $114.4M, fueled by strong demand for genomic tests. Full-year guidance raised to $432M-$438M.
Cathie Wood's ARK shifts focus, selling Ginkgo and Coinbase, while investing in 10X Genomics and Roku in a biotech-centered portfolio ...
Oliver Dowden review of restrictions includes potential curbs on semiconductors and AI, targeting China, Iran, Russia, and North Korea. Cybersecurity ...
Leading genomics company, 10x Genomics, reported a 20% revenue growth in 2023 driven by the successful launch of their Xenium ...
GSK and Elegen partner to develop new vaccines and medicines, harnessing Elegen's DNA manufacturing technology. Collaboration aims to expand genetic ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.